BioRem Inc.

BioRem Inc.

BRM.V
BioRem Inc.CA flagToronto Stock Exchange Ventures
3.07
CAD
- -
- -
49.79MMarket Cap
BioRem Inc.
BRM.V
(Toronto Stock Exchange Ventures)

Recent

price

3.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.44
0.93
1.24
1.51
0.82
1.24
1.03
0.59
0.63
0.53
0.63
0.68
1.86
1.61
2.37
2.64
2.73
Revenue per Share
-0.26
-0.26
-0.07
0.06
-0.13
0.12
0.04
0.04
0.12
-0.03
0.05
0.04
0.1
0.14
0.19
0.3
0.19
Basic EPS, GAAP
-0.18
0.1
-0.04
0.05
-0.04
0.16
-0.04
0.03
-0.01
0.06
0.08
0.1
0.08
- -
0.21
0.45
0.08
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.77
-1.11
-1.22
-1.12
-0.22
-0.06
-0.01
0.13
0.24
0.21
0.26
-0.02
0.05
0.2
0.4
0.69
0.69
Book Value per Share
0.26
- -
-0.03
0.05
-0.02
0.14
0.16
0.19
0.33
0.3
0.35
0.05
0.29
0.43
0.67
0.93
0.94
Tangible Book Value per Share
12
13
12
13
13
14
15
38
39
39
39
36
15
16
16
16
16
Basic Weighted Avg Shares
17
12
15
20
11
17
16
23
24
21
24
24
29
25
37
42
44
Sales/Revenue/Turnover
-12.27
-30.44
-4.21
6.32
-11.95
12.57
4.23
7.35
5.03
-6.3
10.51
9.53
9.15
12.26
11.74
15.52
15.05
Operating Margin (%)
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-3
-3
-1
1
-2
2
1
2
5
-1
2
1
2
2
3
5
3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
21.92
36.23
32.32
21.86
26.63
23.89
23.96
Effective Tax Rate (%)
-18.08
-27.97
-5.38
3.66
-16.12
10
3.44
6.78
19.17
-6.31
8.57
5.3
5.59
8.66
8.13
11.37
6.93
Profit Margin (%)
2
-1
1
- -
1
2
2
7
10
9
10
3
5
6
10
14
15
Working Capital
- -
- -
2
- -
1
- -
- -
- -
- -
- -
1
4
3
3
3
2
2
LT Debt
6
1
- -
1
- -
2
2
7
13
12
14
2
5
7
11
15
15
Total Equity
- -
- -
- -
30.65
- -
52.51
14.3
27.89
- -
- -
16.23
14.43
20.79
22.71
24.59
29.64
30.06
Return on Invested Capital (%)
- -
- -
- -
-11.57
- -
159.17
41.07
45.33
- -
- -
22.08
16.62
34.29
37.32
37.18
41.56
27.03
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
65.73
-14.85
22.82
- -
- -
111.93
64.73
55.42
34.94
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1
1
1
LT Borrowings
1
1
1
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
33
46
40

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
25
31
29
Cash, Cash Equivalents & STI
8
12
10
Accounts Receivable, Net
9
12
9
Inventories
2
1
2
Total Current Liabilities
13
16
14
Payables & Accruals
5
11
7
ST Debt
1
1
1
Deferred Revenue
7
5
6

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
50.11%
38.38%
40.48%
Free Cash Flow
-703.3%
-1,080.19%
119.46%
Net Income, GAAP
4.81%
23.89%
58.25%
Sales/Revenue/Turnover
11.43%
13.48%
13.19%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6
7
15
9
37
2025
5
9
11
17
42
2026
7
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.19
2025
- -
- -
- -
- -
0.3
2026
0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
BioRem Inc. (TSX-V: BRM) is a Canada-based clean technology engineering company that designs, manufactures, distributes and sells air pollution control systems used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs) from industrial and municipal sources. Founded in 1990 and headquartered in Puslinch, Ontario, the company offers biofilters such as modular BASYS and concrete BiofiltAIR systems; biotrickling filters including the MYTILUS line; multi-stage SYNERGY systems combining biotrickling filtration, biofiltration and physical adsorption; biogas desulfurization systems for H2S removal; dry scrubber adsorption systems using activated carbon and impregnated activated alumina; cannabis odor control systems; and biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL and BIOBLOK brands, along with services encompassing media sampling and analysis, biological process testing, full system reviews, inspections, media replacements and spare parts. With over 2,000 installations across 23 countries, BioRem serves industries including wastewater treatment, landfills, agriculture, petrochemicals, food and beverage, chemical production and surface coatings, operating sales and manufacturing offices primarily in North America while exporting to regions such as China, the Middle East and Southeast Asia. In recent developments, the company reported a record order backlog of $71 million as of September 30, 2025, following $17 million in new orders during the quarter and year-to-date bookings of over $24 million through mid-2025, driven by robust bidding activity, strategic expansions in service offerings and integrated solutions, and investments in advanced manufacturing equipment to boost proprietary media production capacity; additionally, BioRem announced approval of a normal course issuer bid and continues to prioritize growth in its service group as a standalone segment amid 47% projected sales growth for 2024 and sustained revenue increases into 2025.